AmerisourceBergen to pay $625 million to settle civil fraud case

The settlement is to resolve allegations that the company illegally repackaged cancer-supportive injectable drugs to profit from overfill

Source: PharmaManufacturing.com - October 1, 2018 Category: Pharmaceuticals Source Type: news